Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes

NCT02312050 is registered in ClinicalTrials.gov with La Jolla Pharmaceutical Company as lead sponsor.

NCT NCT02312050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02312050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
Lead sponsor
La Jolla Pharmaceutical Company
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
December 31, 2016
Enrollment
375 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic chronic kidney disease